Sep 2026· Journal of Healthcare Quality Research· Vol 42 1, pp.
101235
· 0 citations· 28 references
Medicine
TL;DR
The SDM model is a feasible and acceptable framework for the integration of SDM into hospital workflows and its pilot implementation improved patient knowledge and engagement, supporting its scalability and further evaluation of long-term impact and sustainability.
Abstract
INTRODUCTION AND
Objectives
Shared decision-making (SDM) is a core component of patient-centred care, with proven benefits for decision quality and satisfaction. However, its implementation in hospital settings remains limited. This study aimed to describe the development of a SDM model and to evaluate its feasibility, acceptability, and preliminary effects through two pilot implementation studies.
Methods
We used a mixed-methods design including the co-creation of an SDM implementation model and two comparative pilot evaluations. Development involved a multidisciplinary team. Pilot implementation was tested with patients with class 3 obesity (n=50) and advanced chronic kidney disease (ACKD; n=38) recruited from outpatient services. The SDM model is a six-step framework comprising clinical decision prioritisation, co-creation of patient decision aids, healthcare professional training, and staged implementation following the three-talk model. Outcomes included feasibility (recruitment and ≥80% process completion), intervention acceptability, and preliminary decision quality indicators (knowledge, satisfaction, decisional conflict) and SDM process measures (SDM-Q-9, CollaboRATE).
Results
Feasibility thresholds were achieved in both pathways, with high adherence. In obesity, SDM participants reported greater knowledge (80.0% vs 48.8%; p<0.001) and higher decision satisfaction (28.0 vs 24.2; p=0.022). In ACKD, SDM participants also showed significantly higher knowledge (91.1% vs 37.1%; p<0.001), while satisfaction and process outcomes were similar between groups.
Conclusion
Our SDM model is a feasible and acceptable framework for the integration of SDM into hospital workflows. Its pilot implementation improved patient knowledge and engagement, supporting its scalability and further evaluation of long-term impact and sustainability.
This study aims to develop a generic COS for evaluating the impact of SDM interventions (COS-SDMi), developed in the context of rheumatology, and disseminated through presentations at international conferences, briefing notes to key organisations and publication in a peer-reviewed journal.
C. Hoffmann, J. Butterworth, F. Naye et al.· BMJ Open· 0 citations
Overall, SDM showed potential benefits in improving patient involvement and decision quality, although evidence remained heterogeneous and limited, and shows a promising but underdeveloped application in stroke care.
Shu-Ting Wang, Ling Liu, Li-Li Yao et al.· BMJ Open· 0 citations
A pragmatic tool to support CPG developers in identifying and prioritizing recommendations for which SDM may be particularly relevant, and to test FOCUS within CPG development processes to assess its applicability, appropriateness, usefulness, and discriminative performance.
Clara Orduhan, L. V. Schewe, Lena Fischer et al.· Journal of Clinical Epidemio...· 0 citations
499
Background:
Learning health systems (LHSs) prioritize stakeholder engagement to understand contextual factors that shape implementation processes and outcomes, but less attention is given to how engagement and co-design are operationalized in clinical settings. Patient reported outcome measures (PROMs) are...
Farah Elsiss, Eric Adjei Boakye, Ashley Redding et al.· JCO Oncology Practice· 0 citations
Abstract Objectives Human Factors (HF) principles are essential for safe and effective clinical decision support (CDS), yet existing guidance is fragmented and rarely evaluated in real world settings. A novel, evidence-based, vendor-agnostic HF-informed guideline was developed to address this gap. This study evaluated...
Selvana Awad, Thomas Loveday, Andrew J. Baillie et al.· JAMIA Journal of the America...· 0 citations
Background Multiple myeloma (MM) is characterized by complex and evolving treatment pathways, involving multiple preference-sensitive decisions across the disease trajectory. Shared decision-making (SDM) is widely recognized as a best-practice approach for such decisions, yet practical, context-specific guidance for im...
Jolien Broekmans, Elise Schoefs, Charlotte Verbeke et al.· PLoS ONE· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.